MedTrace Logo

ACE and HLA Genotypes Predict Severity and Disease Progression in Danish Sarcoid Patients

NCT04462068 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2024-01-25

No results posted yet for this study

Summary

Sarcoidosis is a multisystem granulomatous disease of unknown cause histologically characterized by noncaseating granulomas. Genetic factors affect disease course, which is highly variable and difficult to predict.

This study aims to evaluate the predictive value of ACE and HLA genotypes on disease severity and progression in Danish patients with sarcoidosis.

Conditions

  • Sarcoidosis

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-01
Primary Completion
2023-11-30
Completion
2023-11-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04462068 on ClinicalTrials.gov